Megan J Kaleita Says Wegovy Cut 20 Years of Autoimmune Pain Within 2 Weeks
Updated
Updated · BuzzFeed · Jun 7
Megan J Kaleita Says Wegovy Cut 20 Years of Autoimmune Pain Within 2 Weeks
1 articles · Updated · BuzzFeed · Jun 7
Summary
Two weeks after starting Wegovy in May 2024, Megan J Kaleita says chronic pain and fatigue tied to multiple autoimmune syndrome eased sharply, letting her swim three days a week after struggling to walk half a mile.
Kaleita, 41, says the drug helped manage inflammation, weight gain and binge-eating cycles linked to rheumatoid arthritis, polymyositis and Hashimoto’s, with side effects she describes as minimal to none under medical supervision.
Her essay argues public backlash against GLP-1 drugs often ignores patients using them for complex medical needs, citing stigma around fatness, chronic illness and private treatment decisions.
Kaleita says shortages, celebrity misuse and overprescription are real concerns, but not grounds to shame informed adults discussing GLP-1 treatment with trusted doctors as researchers study the drugs for autoimmune disease.